Home
/

What is an HDL Cholesterol Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

HDL cholesterol measures the cholesterol carried by high-density lipoprotein particles that transport excess cholesterol from tissues back to the liver. Low HDL (<40 mg/dL in men, <50 in women) is associated with increased cardiovascular risk, especially when clustered with high triglycerides and insulin resistance. HDL-C is interpreted alongside other lipid markers to assess metabolic and cardiovascular health.

Read more →
Table of contents

HDL cholesterol: the cargo carried by high-density lipoproteins

HDL cholesterol in a blood test is the amount of cholesterol carried inside high-density lipoproteins. These are tiny, protein‑rich particles made mainly by the liver and small intestine (HDL particles containing apolipoprotein A‑I). HDL is part of the body’s lipoprotein system that transports fats through the blood. In circulation, nascent HDL picks up free cholesterol from cells, and remodeling turns it into compact, cholesterol‑laden HDL that travels widely.

HDL’s central job is to move excess cholesterol away from vessel walls and other tissues back to the liver for reuse or removal (reverse cholesterol transport). By shuttling cholesterol and hosting protective enzymes, HDL helps keep artery linings healthy, reduces oxidation and inflammation, and supports normal blood‑vessel tone (antioxidant, anti‑inflammatory, and endothelial effects). The HDL cholesterol result therefore serves as a proxy for the body’s capacity to clear cholesterol through HDL pathways, though it reflects the cholesterol cargo rather than the number of HDL particles or how well they function.

Why HDL maps to reverse cholesterol transport and cardiometabolic tone

HDL cholesterol is the bloodstream’s cleanup crew. It ferries excess cholesterol away from vessel walls back to the liver, dampens inflammation, neutralizes oxidative stress, and helps the endothelium—the lining of your arteries—stay flexible. Because it touches lipid transport, immunity, and metabolic signaling, HDL reflects how well your body prevents plaque formation across the entire vascular system.

Big picture: HDL is a systems biomarker linking liver, vessels, immune tone, and glucose metabolism. It’s best interpreted alongside triglycerides, LDL/apoB, non-HDL cholesterol, and inflammatory markers to understand long-term cardiovascular risk and arterial health.

How low, mid-range, and very high HDL-C tend to behave

Most labs consider values around 40–60 common, and cardiovascular protection generally improves as you move toward the higher end. Men tend to run lower than women; in women, values below about 50 are considered low. Children and teens usually have higher HDL when they are lean and active. During pregnancy, HDL often rises mid-gestation as lipid transport shifts to support the fetus.

When HDL is low—below about 40 in men or 50 in women—it often signals insulin resistance and high triglyceride traffic, with the liver pushing out VLDL and the artery wall exposed to more apoB-containing particles. This pattern accelerates plaque growth, clusters with abdominal weight gain, elevated blood pressure, and fatty liver, and is usually silent until vascular disease declares itself with effort-related chest discomfort or reduced exercise tolerance.

Very high readings can be a mixed message. Moderately higher HDL often tracks with better reverse cholesterol transport, but extreme levels (roughly above 80–90) may reflect genetic variants or dysfunctional HDL and don’t always translate to lower risk; alcohol use and certain liver or inflammatory states can also skew the number.

Low values usually reflect insulin resistance with high triglycerides and visceral adiposity, leading to reduced cholesterol efflux and more atherogenic lipoproteins. System effects include impaired endothelial signaling, higher vascular inflammation, and increased cardiometabolic risk. Men commonly have lower HDL than women; levels tend to fall after menopause. Acute illness and androgen exposure can also depress HDL.

Being in range suggests effective reverse cholesterol transport, better lipid balance, and more resilient vascular and immune signaling. For most groups, risk tends to be lower when HDL sits in the mid-to-high portion of the sex-specific reference range, though function matters more than absolute concentration.

High values usually reflect genetic variants (such as CETP or SCARB1-related changes), medication or hormone effects, alcohol exposure, or certain liver or thyroid conditions. Very high HDL can indicate dysfunctional particles and has been linked to a U-shaped risk curve for cardiovascular events and infections, particularly in men.

Fasting, inflammation, hormones, and lifestyle inputs

Fasting is optional but mixed-meal states and acute inflammation can shift results. Pregnancy and estrogen therapy raise HDL; androgens and some illnesses lower it. HDL-C is a concentration measure and does not directly capture particle number or function. Assay methods and age/sex differences influence interpretation.

HDL-C is most informative read with ApoB or LDL particle number, triglycerides, non-HDL cholesterol, and inflammatory markers like hs-CRP. This combination separates protective HDL function from genetic outliers and clarifies whether the wider lipid pattern points to insulin resistance or atherogenic risk.

FAQs

HDL Cholesterol testing measures the amount of cholesterol carried by high-density lipoproteins in your blood, reflecting reverse cholesterol transport and contributing to your cardiovascular risk profile.

Testing establishes a baseline, tracks changes over time, and clarifies risk when viewed with LDL, non-HDL cholesterol, triglycerides, and ApoB, especially in the context of metabolic health.

Many people measure HDL as part of routine lipid panels annually, with more frequent checks when tracking lifestyle changes, weight shifts, training cycles, or life-stage transitions.

Genetics, sex hormones, physical activity, diet quality, weight status, smoking, alcohol intake, insulin resistance, medications, thyroid function, and liver health can all influence HDL.

HDL Cholesterol itself is not strongly affected by fasting, but fasting is often recommended for a standard lipid panel to improve triglyceride assessment and overall interpretation.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Mackey, R. H., Greenland, P., Goff, D. C., Lloyd-Jones, D., Sibley, C. T., & Mora, S. (2012). High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis). Journal of the American College of Cardiology, 60(6), 508-516. https://doi.org/10.1016/j.jacc.2012.03.060
  2. Rosenson, R. S., Brewer, H. B., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., Krauss, R. M., Otvos, J. D., Remaley, A. T., & Schaefer, E. J. (2011). HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clinical Chemistry, 57(3), 392-410. https://doi.org/10.1373/clinchem.2010.155333
  3. Emerging Risk Factors Collaboration. (2009). Major lipids, apolipoproteins, and risk of vascular disease. JAMA, 302(18), 1993-2000. https://doi.org/10.1001/jama.2009.1619
  4. Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., Goldberg, R., Heidenreich, P. A., Hlatky, M. A., Jones, D. W., Lloyd-Jones, D., Lopez-Pajares, N., Ndumele, C. E., Orringer, C. E., Peralta, C. A., ... Yeboah, J. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol. Circulation, 139(25), e1082-e1143. https://doi.org/10.1161/CIR.0000000000000625
  5. Kontush, A. (2015). HDL particle number and size as predictors of cardiovascular disease. Frontiers in Pharmacology, 6, 218. https://doi.org/10.3389/fphar.2015.00218

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey